Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CHROnic Migraine Embolization

NCT: NCT06848166 · ENROLLING_BY_INVITATION

NCT IDNCT06848166
StatusENROLLING_BY_INVITATION
Start Date2024-10-17
Completion2029-05
SponsorVedanta University Clinic (OTHER)
First posted
Last updated

Brief Summary

To evaluate the effectiveness and safety of middle meningeal artery (MMA) embolization using non-adhesive materials SQUID 12 and SQUID 18 as a treatment method for patients with chronic resistant migraine.

Frequently Asked Questions

What is CHROnic Migraine Embolization?

CHROnic Migraine Embolization is a clinical trial registered under NCT06848166. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT06848166?

The current status of NCT06848166 (CHROnic Migraine Embolization) is: ENROLLING_BY_INVITATION.

When did CHROnic Migraine Embolization start?

CHROnic Migraine Embolization started on 2024-10-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.